animals | opacc

Clinical trials in dogs could lead to child cancer cures

Dogs with cancer are moving the needle forward on childhood cancer research. Read more here: http://www.coloradoan.com/story/news/2015/08...

Study shows pet therapy may help childhood cancer patients

More than 13,000 children are diagnosed with cancer each year, and many of them have to endure painful treatments that trigger stress,...

Study tests whether dog visits can ease stress of young cancer patients

A group of young patients at UC Davis Comprehensive Cancer Center is part of a nationwide study that examines the effects of...

Clinical Trial Launches to Document Efficacy of Animal-Assisted Therapy for Child Cancer Patients an

Zoetis Inc. and American Humane Association today announced the official launch of the full clinical trial of the Canines and Childhood...

Canines and Childhood Cancer Research Study

In 2010, American Humane Association and Zoetis partnered to launch the Canines and Childhood Cancer (CCC) Study, a groundbreaking...

Examining The Effect of Therapy Dogs With Childhood Cancer Patients

Billions of dollars are being spent each year to better prevent and treat childhood cancer cases, but until there is a cure, what can we...

New Research to Evaluate Benefits of Animal-Assisted Therapy for Kids with Cancer

Pfizer Animal Health, an international leader in the advancement of animal health, and the American Humane Association, the nation’s...

FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma

After my daughter's cancer, I wanted to control her entire life. Then she went to college.

When Childhood Cancer Survivors Face Sexual Challenges

Early interventions may improve long-term academic achievement in young childhood brain tumor survivors

Immunotherapy for children with primary liver carcinomas: Research offers new hope

Pediatric psychologist explains how to support your child's development after a cancer diagnosis

Adult Survivors of Childhood Cancer Have High Prevalence of Chronic Pain

Spontaneous Remission in Childhood Cancer Rare but Fleeting

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma